Ilan brings more than 20 years of experience in R&D and management in the medical device industry.  In addition to co-founding Digma, he served as founder and CTO of Eximo Medical (acquired by AngioDynamics), was the CTO of Exalenz Bioscience Ltd., (acquired by Meridian BioScience) and was CTO at Oridion Medical (acquired by Covidien).  Ilan is the author of more than 40 patents and patent applications in the field of medical technologies and electro-optics. Mr. Ben-Oren holds a master’s degree in applied physics and the science of materials summa cum laude from the Hebrew University of Jerusalem.

ILAN BEN-OREN

Co-founder and CTO

Hila has over 10 years of experience in medical device regulatory, clinical affairs and quality assurance.  Prior to Digma, Hila was Vice President, Clinical and Regulatory Affairs in a wearable telemedicine startup where she built and led the regulatory strategy, clinical affairs and quality system infrastructure.  Prior to that, Hila was a researcher and project manager in other medical device companies in the field of wound care and stem cells regenerative medicine.  Dr. Dagan holds a PhD in Biotechnology from Tel Aviv University in the field of nano-biotechnology, an M.Sc. from Tel Aviv University and a B.Sc. in biology from The Hebrew University of Jerusalem.

HILA DAGAN, PhD

Head of Regulatory, Clinical and Quality

Brian brings over 25 years of clinical and research experiences within the endocrinology, diabetes and metabolism community.  Prior to Digma, he served as CMO & Worldwide VP of Clinical Affairs of Johnson & Johnson Diabetes Care Companies where he oversaw all of clinical and medical affairs of the group.  Before that, he served as Global Medical Affairs Leader for Metabolic Disease at Janssen Pharma, where he led the INVOKANA (canagliflozin) medical affairs program. Dr. Levy was on faculty at NYU School of Medicine, where he remains an attending physician at Bellevue Hospital. He received his B.A. at Cornell University, his M.D. from Johns Hopkins University School of Medicine, and completed his residency & fellowship in Endocrinology & Metabolism at NYU Medical Center.

BRIAN L. LEVY, MD, FACE

Chief Medical Officer

Shlomit  joined Digma Medical as VP of R&D in 2021 and brings more than 15 years of R&D management experience, including leading multidisciplinary teams in the development of Class II and III medical devices from early prototype to formal product development and through manufacturing transfer.  Previously, Shlomit served as VP R&D at Nano-Dimension Technologies and in roles of increasing responsibility at Edwards Life Sciences and Medinol Ltd.  Dr. Chappel-Ram holds a BSc (Summa Cum Laude) in Physical Chemistry, Ph.D. (Summa Cum Laude) specialized in Photo-electrochemistry and Materials Science and a MBA from Bar-Ilan University, Israel.

SHLOMIT CHAPPEL-RAM, PhD

Vice President, R&D

Yaniv has over 20 years of experience in leading large and small scale cross-organizational teams in the medical and defense industry, including management of multidisciplinary R&D and operation projects and teams. Prior to joining Digma, Yaniv was Vice President R&D and Site Manager of Endochoice Innovation Center (acquired by Boston Scientific).  Yaniv also worked in product management at Stryker Endoscopy and began his career as a technical team leader at Elbit Systems.  Mr. Kirma holds a BSc in Electrical Engineering and Physics from the Technion, Haifa.

YANIV KIRMA

COO and Site Manager

James joined Digma as President and CEO in 2020.  Prior to Digma, he led the global commercial organization at GenMark Diagnostics (acquired by Roche) and held roles of increasing responsibility with Volcano Corporation (acquired by Philips) in sales, marketing and general management.  James has also worked in R&D in Boston Scientific’s endoscopy business and he began his career in Morgan Stanley’s investment banking division.  Mr. McNally received a B.S.E. in Electrical Engineering with high honors from Princeton University, an M.S. degree in Optical Sciences from the University of Arizona, and an M.B.A. with high distinction from Harvard Business School where he was a George F. Baker Scholar and a Robert S. Kaplan Life Sciences Fellow.

JAMES MCNALLY

President and CEO